PANREAC presents a new line of excipients for the pharmaceutical industry according to the IPEC guide
PANREAC specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries.
PANREAC, since its founding in 1941 is one of the Spanish leading companies specialized in the manufacturing of reagents for laboratory analysis, excipients and bulk chemicals to be used as raw materials in the pharmaceutical, cosmetic and food industries.
PANREAC has become a benchmark company in the pharmaceutical manufacturing process for their high quality standards established from the start. Since the company’s beginnings, they offered high purity products PRS for Pharmaceutical applications, becoming later the “PRS-CODEX’, an important level of commitment with the main pharmacopeias. Over last year they have launched a new line of excipients for the pharmaceutical industry fulfilling the guidelines of IPEC.
At the moment, Panreac Pharma counts with more than 300 raw materials for the pharmaceutical and biotechnology industry to be used as excipients or during the manufacturing process.
High Standards of Quality
The excipients are the main ingredient of the medicines in terms of volume and weight; therefore, they have an important function on the final product. For this reason, PANREAC has adopted the IPEC-PQG GMP guide for pharmaceutical excipients (2006), to ensure product consistent conformity through and integral control policy which Panreac has integrated into its manufacturing processes.
The line has an incredible detailed process description including registration, validation and release procedures and also supports supplier audits, upstream and downstream traceability and has a production sample storage. Furthermore, PANREAC has trained specialized workforce to assure the best quality and safety for the pharmaceutical industry and its potential consumers, offering maximum purity, reliability and a firm commitment to society that is finally translated into success and progress. PANREAC has built an exclusive “Clean Room Panreac Pharma” aimed just to develop excipients within strict work conditions in terms of hygiene and contamination control.
PANREAC also disposes of the ISO 9001:2008 on quality management, ISO 14002:2004 on environmental protection and OHSAS 18001:2007 on the safety and health at work, three more commitments that justify one of their main company values: be at the leading edge of quality assurance in the sector.
Fast market development
For seven decades PANREAC has succeed in satisfying the needs of their costumers thanks to their extensive experience, their constant product innovation and quality research.
Thereby, in order to respond the constant increasing market demands, PANREAC disposes of a 15000 m2 high-tech production plant near Barcelona that allows them to optimize flexibility and efficiency in their production. Moreover, since 2008 they developed a new 8000 m2 technologically equipped warehouse to provide the best service to customers and distributors.
Particularly, the company has worked hard to truly expand their products and services internationally. So, for this reason, in 1999 they opened their first two subsidiaries in France and Portugal. Lately in 2007 PANREAC bought the Italian company Nova Chimica, allowing them to get faster in the European market. In 2010 Panreac became part of the chemical division (performance polymers and fluids group) of Illinois Tool Works (ITW), an $18 billion per year U.S. industrial conglomerate.
Nowadays, PANREAC exports their products to more than 80 countries in the world, thanks to their growing and expanding distribution network.
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Understanding the Benefits and Advances of Cleanroom Technology
In an industry where precision and sterility are crucial concerns, cleanrooms play a vital role in maintaining the integrity of pharmaceutical products like drugs, vaccines, and other medical products. So, what is a cleanroom?
-
News From Pharma to Table? Direct-to-consumer pharma sales and price cuts ramp up in US
The pharmaceutical industry is witnessing a seismic shift as major companies embrace direct-to-consumer sales models and announce significant price reductions across the United States, responding to mounting pressure from the Trump administration to ta... -
News A Day in the Life of a Director of Business Development
In this Day in the Life of interview, Thomas Hauser, Director of Business Development at Tjoapack. Thomas has spent nearly 30 years in the pharmaceutical industry and describes how he still finds curiosity and excitement in the bigger picture of global... -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective.